Syntax Research’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Syntax Research's JNJ Position: Q2 2026 in Review
Syntax Research reduced its Johnson & Johnson (JNJ) stake by 54% in Q2 2026, selling an estimated $51.5K and leaving 190 shares worth $48.3K. The position accounts for 0.04% of the portfolio, ranked #94.
Syntax Research first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. The position peaked at $100K in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Syntax Research held 190 shares of Johnson & Johnson worth $48.3K as of Q2 2026.
- Syntax Research sold 221 Johnson & Johnson shares in Q2 2026, an estimated $51.5K.
- Johnson & Johnson made up 0.04% of Syntax Research's portfolio in Q2 2026, its #94 holding.
- Syntax Research first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
- Syntax Research's Johnson & Johnson position peaked at $100K in Q1 2026.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.